Founded in 1978, Kahn Brothers (Trades, Portfolio) & Co. Inc. currently manages more than $800 million in assets. The firm sold shares of the following stocks during the first quarter.
The New York Times Co. (NYT, Financial) position was reduced by 45.33%. The trade had an impact of -2.24% on the portfolio.
The American media company has a market cap of $5.45 billion and an enterprise value of $5.09 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 12.87% and the return on assets of 5.91% are outperforming 67% of companies in the Publishing industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 2.42 is above the industry median of 1.36
Another notable guru shareholder of the company is Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 0.34% of outstanding shares, followed by Paul Tudor Jones (Trades, Portfolio) with 0.08% and Steven Cohen (Trades, Portfolio) with 0.03%.
The firm trimmed 38.12% off its Hologic Inc. (HOLX, Financial) holding, impacting the portfolio by -1.56%.
The company, which manufactures medical devices, has a market cap of $12.24 billion and an enterprise value of $14.97 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of -0.45% and return on assets of -0.15% are outperforming 87% of companies in the Medical Instruments and Supplies industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.13 is below the industry median of 1.74.
The company's largest guru shareholder is Larry Robbins (Trades, Portfolio) with 3.40% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 1.06% and Pioneer Investments (Trades, Portfolio) with 0.69%.
Kahn Brothers curbed its Merck & Co. Inc. (MRK, Financial) position by 5.39%, impacting the portfolio by -0.59%.
The pharmaceutical company has a market cap of $201.22 billion and an enterprise value of $217.65 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 26.30% and return on assets of 9.84% are underperforming 56% of companies in the Drug Manufacturers - Major industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.32 is below the industry median of 0.64.
The company's largest guru shareholder is Vanguard with 0.70% of outstanding shares, followed by Pioneer Investments with 0.36% and Ken Fisher (Trades, Portfolio) with 0.33%.
The Sterling Bancorp (STL, Financial) holding was reduced 24.49%, impacting the portfolio by -0.44%.
The bank holding company has a market cap of $4.51 billion and an enterprise value of $4.09 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. The return on equity of 10.08% and return on assets of 1.46% are outperforming 53% of companies in the Banks - Regional - U.S. industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.09 is below the industry median of 1.43.
The company's largest guru shareholder is Diamond Hill Capital (Trades, Portfolio) with 1.54% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 0.55%.
The firm curbed its Citigroup Inc. (C, Financial) position by 2.79%, impacting the portfolio by -0.25%.
The bank has a market cap of $157.62 billion.
GuruFocus gives the company a profitability and growth rating of 3 out of 10. The return on equity of 8.45% and return on assets of 0.94% are underperforming 59% of companies in the Banks - Global industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.73 is below the industry median of 1.43.
The company's largest guru shareholder is Jeff Ubben (Trades, Portfolio)'s ValueAct with 1.43% of outstanding shares, followed by Hotchkis & Wiley with 0.56%, Diamond Hill Capital with 0.44% and Bill Nygren (Trades, Portfolio) with 0.41%.
Kahn Brothers trimmed its Seaboard Corp. (SEB, Financial) holding by 4.73%, impacting the portfolio by -0.23%.
The global food, energy and transportation company has a market cap of $5.02 billion and an enterprise value of $4.52 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. The return on equity of -0.24% and return on assets of 0.15% are outperforming 53% of companies in the Conglomerates industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 1.49 is below the industry median of 1.66.
The company's largest guru shareholder is Kahn Brothers with 0.63% of outstanding shares, followed by Simons’ firm with 0.49%, Third Avenue Management (Trades, Portfolio) with 0.14% and Jones with 0.02%.
Disclosure: I do not own any stocks mentioned.
Read more here:
- Parnassus Endeavor Fund Buys AbbVie, Boosts Biogen
- 5 Stocks With Low Price-Earnings Ratios
- Yacktman Asset Management Buys Alphabet, Walt Disney
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
